[Use of 5-butyl-1-cyclohexyl-2,4,6,-trioxoperidropyrimidine (BCP) in the prevention and therapy of neonatal hyperbilirubinemia. Comparative study with phenobarbital].

[Use of 5-butyl-1-cyclohexyl-2,4,6,-trioxoperidropyrimidine (BCP) in the prevention and therapy of neonatal hyperbilirubinemia. Comparative study with phenobarbital]. — المؤلف: Centa, A — Minerva pediatrica Apr 1976

المؤلف
Centa, A
النشر
Minerva pediatrica Apr 1976
الوصف
911-21 p.
الموضوعات
Barbiturates؛ Drug Evaluation؛ Humans؛ In Vitro Techniques؛ Infant, Newborn؛ Jaundice, Neonatal؛ Male؛ Phenobarbital